https://www.nature.com/articles/d41586-023-02321-1
0
0
Alzheimer's drug donanemab helps most when taken at earliest disease stage, study finds - Nature.com
7/18/23 at 12:22am
Organization
Nature.com
Authors
Details
37 words
Summarize
Neurological Conditions Aging & Geriatrics donanemab disease stage Nature.com protein amyloid
But the drug, an antibody that attacks the protein amyloid, does not work as well in people with more advanced disease.
Create an account or login to join the discussion